covaxin

DCGI Gives Emergency Use Okay to Covovax for 12-17 Year Olds

FDA Declines Emergency-Use Approval for Covaxin for Paediatric Use

India Has Nine COVID-19 Vaccines. Seven Are Available Only in the Headlines.

10 Billion COVID-19 Vaccine Doses Later, What’s India’s Contribution?

How Much Has Govt Paid Vaccine Makers? Two Govt Replies Differ by Rs 1,000 Cr

Early Signs of COVID Cases Plateauing, but Situation Needs To Be Observed: Govt

Centre’s Expert Panel Recommends Regular Market Approval for Covishield, Covaxin